The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group

The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group

Background: Vedolizumab is an approved ulcerative colitis (UC) treatment. Multiple large randomized clinical trials have demonstrated the drug’s efficacy and safety. However, real-world data from Middle Eastern countries are spare. The study aims to evaluate the clinical efficacy of vedolizumab (VDZ...

Full description

Saved in:
Bibliographic Details
Main Authors: Nahla Azzam, Othman Alharbi, Mansour Altuwaijri, Yazed Alruthia, Heba Alfarhan, Suliman Alshankiti, Faris Nafisah, Qusay Ajlan, Abdulrahman Aljebreen, Majid Almadi, Mahmoud H. Mosli
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
advanced therapy
ibd
ulcerative colitis
vedolizumab
Online Access:https://journals.lww.com/10.4103/sjg.sjg_249_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/sjg.sjg_249_24

Similar Items